Annual FCF
-$2.60 M
-$1.24 M-91.33%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual free cash flow is currently -$2.60 million, with the most recent change of -$1.24 million (-91.33%) on 31 December 2023. During the last 3 years, it has fallen by -$1.79 million (-221.52%). GDTC annual FCF is now -221.52% below its all-time high of -$808.40 thousand, reached on 01 December 2020.GDTC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.3% | - | - |
| 3 y3 years | -221.5% | - | - |
| 5 y5 years | - | - | - |
GDTC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -221.5% | at low | ||||
| 5 y | 5 years | -221.5% | at low | ||||
| alltime | all time | -221.5% | at low |
CytoMed Therapeutics Limited Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2.60 M(+91.3%) | - | - |
| Dec 2022 | -$1.36 M(-20.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.71 M(+111.3%) | - | - |
| Dec 2020 | -$808.40 K | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual free cash flow?
- What is the all time high annual FCF for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual FCF year-on-year change?
What is CytoMed Therapeutics Limited annual free cash flow?
The current annual FCF of GDTC is -$2.60 M
What is the all time high annual FCF for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual free cash flow is -$808.40 K
What is CytoMed Therapeutics Limited annual FCF year-on-year change?
Over the past year, GDTC annual free cash flow has changed by -$1.24 M (-91.33%)